Compass Ion Advisors’s Eli Lilly LLY Stock Holding History

Compass Ion Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.95M	Buy	2,121 +48	+2%	+$48.7K	0.19%	68
2025 Q4	$2.23M	Sell	2,073 -92	-4%	-$88K	0.21%	57
2025 Q3	$1.65M	Buy	2,165 +86	+4%	+$64K	0.16%	73
2025 Q2	$1.62M	Sell	2,079 -291	-12%	-$226K	0.18%	68
2025 Q1	$1.96M	Buy	2,370 +18	+0.8%	+$15K	0.23%	53
2024 Q4	$1.82M	Sell	2,352 -4	-0.2%	-$3.31K	0.22%	60
2024 Q3	$2.09M	Buy	2,356 +16	+0.7%	+$14.4K	0.26%	55
2024 Q2	$1.82M	Hold	2,340	–	–	0.26%	54
2024 Q1	$1.82M	Buy	2,340 +117	+5%	+$83.3K	0.26%	55
2023 Q4	$1.3M	Buy	2,223 +598	+37%	+$349K	0.2%	72
2023 Q3	$873K	Buy	+1,625	New	+$837K	0.15%	97

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Compass Ion Advisors's LLY Position: Q1 2026 in Review

Compass Ion Advisors increased its Eli Lilly (LLY) stake by 2.3% in Q1 2026, buying an estimated $48.7K and bringing the position to 2,121 shares worth $1.95M. The position accounts for 0.19% of the portfolio, ranked #68.

Compass Ion Advisors first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.23M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Compass Ion Advisors held 2,121 shares of Eli Lilly worth $1.95M as of Q1 2026.
Compass Ion Advisors bought 48 Eli Lilly shares in Q1 2026, an estimated $48.7K.
Eli Lilly made up 0.19% of Compass Ion Advisors's portfolio in Q1 2026, its #68 holding.
Compass Ion Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
Compass Ion Advisors's Eli Lilly position peaked at $2.23M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Compass Ion Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.